Scimago Lab
powered by Scopus
Formerly the IP & Science
business of Thomson Reuters


eISSN: 1643-3750

Get your full text copy in PDF

Treatment of chronic hepatitis C virus - current status, prospects

Małgorzata Pawłowska, Waldemar Halota, Arkadiusz Kuziemski

Med Sci Monit 1997; 3(6): RA943-947

ID: 501844

Chronic results of HCV infection constitute an important clinical problem. Its importance has not yet been fully recognised, and therapeutic possibilities are limited. Since several years interferon has been administered as the basic drug. Clinical studies are carried out in order to improve its efficacy by combining this drug with other antiviral drugs, by modifying the dose and treatment duration, and by preventing chronic liver diseases through the inclusion of interferon in treatment of acute virus C hepatitis.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree